Given that dysregulation of TLR4 signaling in DCs can lead to a range of immune dysfunctions that contribute to various pulmonary diseases, it is essential to explore these underlying mechanisms in greater detail to identify new targets for treatment. The gene discussed is TLR4; the disease is lung disorder.